MedPath

Post-Approval Study of the Tecnis® Toric IOL

Not Applicable
Completed
Conditions
Cataract
Registration Number
NCT02566083
Lead Sponsor
Abbott Medical Optics
Brief Summary

This study is a prospective, multicenter, bilateral, non-randomized, open-label, comparative clinical study conducted at up to 80 sites in the USA. Subjects will choose to be bilaterally implanted with either 1) the TECNIS 1-Piece Toric IOLs, Model ZCT300 and/or ZCT400, or 2) the TECNIS Monofocal Model ZCB00 non-toric control IOL, according to subject preference

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
365
Inclusion Criteria
  • Minimum 22 years of age

  • Bilateral cataracts

  • Preoperative keratometric cylinder in both eyes

  • Most appropriate toric IOL model choice (ZCT300 or ZCT400)

  • Predicted residual refractive cylinder, based on the AMO Toric IOL Calculator, must be:

    ≤ 0.69 D for a ZCT300 IOL or ≤ 0.88 D for a ZCT400 IOL

  • Clear intraocular media other than cataract in each eye

  • Availability, willingness, ability and sufficient cognitive awareness to comply with examination procedures and study visits

  • Ability to understand, read and write English in order to consent to study participation and complete a study questionnaire

  • Signed informed consent and HIPAA authorization

Exclusion Criteria
  • Irregular corneal astigmatism
  • Any corneal pathology/abnormality other than regular corneal astigmatism
  • Previous corneal surgery
  • Recent ocular trauma or intraocular surgery that is not resolved/stable or may affect visual outcomes
  • Any pupil abnormalities
  • Subjects with conditions associated with increased risk of zonular rupture, including capsular or zonular abnormalities that may lead to IOL decentration, including pseudoexfoliation, trauma, or posterior capsule defects
  • Known ocular disease or pathology that may affect visual acuity or that may require surgical intervention during the course of the study
  • Concurrent participation or participation during 30 days prior to preoperative visit in any other clinical study
  • Planned monovision correction
  • Patient is pregnant, plans to become pregnant, is lactating or has another condition associated with the fluctuation of hormones that could lead to refractive changes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Rate of Severe Visual Distortions6 months

The rate of severe visual distortions under overall circumstances for the five visual distortion items of interest (lines that slant, tilt, split or separate; flat surfaces appearing curved; objects appearing further away or closer than they are; objects appearing to have a different size or shape; and physical discomfort related to vision). The six month data were used for this endpoint if available and if not an earlier visit was used. If a subject had a lens repositioning the questionnaire prior to the repositioning was used if available.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (44)

Eye Center South

🇺🇸

Dothan, Alabama, United States

Arizona Eye Cente

🇺🇸

Chandler, Arizona, United States

Fishkind, Bakewell & Maltzman Eye Care & Surgery Cente

🇺🇸

Tucson, Arizona, United States

Boozman-Hof Regional Eye Clinic

🇺🇸

Rogers, Arkansas, United States

Empire Eye & Laser Center

🇺🇸

Bakersfield, California, United States

Atlantis Eye Care

🇺🇸

Huntington Beach, California, United States

Scripps Clinic Medical Group

🇺🇸

La Jolla, California, United States

Southern California Eye Physicians & Associates

🇺🇸

Long Beach, California, United States

Feinerman Vision Center

🇺🇸

Newport Beach, California, United States

Coastal Vision

🇺🇸

Orange, California, United States

Scroll for more (34 remaining)
Eye Center South
🇺🇸Dothan, Alabama, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.